AGP Executive Report
Last update: 9 minutes agoPublic Health Alert: The Netherlands has reported its first West Nile virus infection since 2020, according to RIVM. The person had mild symptoms and had not recently travelled, suggesting local transmission via mosquitoes. Medical Research: Amsterdam UMC researchers report that an existing blood pressure drug, guanabenz, may slow progression of vanishing white matter, a rare and often fatal childhood brain disease, in a Lancet Neurology study. Immunology Update: Belgian-Dutch biotech argenx says efgartigimod met the primary goal in a Phase 3 trial for autoimmune myositis, with significant improvement in disease activity at 52 weeks versus placebo. Healthcare Access & Costs: A survey of Dutch AOW recipients finds 69% are postponing larger or nonessential purchases due to rising living costs, with energy, groceries and even health-related expenses squeezing budgets. Policy & Care: The Jetten Cabinet begins talks with opposition parties ahead of the September 15 budget deadline, with healthcare deductible increases among the sticking points.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
